Proteome: Proteome secures $1m-plus contract with US biopharma firm
Proteome Sciences announced on Friday that it has secured a contract worth over $1m from a US biopharmaceutical company for the use of its mass spectrometry services in an ongoing clinical trial.
Read full article »
Proteome Sciences is a life sciences company that engages in the research and development of novel protein biomarker for diagnosis of cancer.
Read more